[go: up one dir, main page]

FR1320009A - Process for the purification or concentration of live virus or antigenic substance derived therefrom - Google Patents

Process for the purification or concentration of live virus or antigenic substance derived therefrom

Info

Publication number
FR1320009A
FR1320009A FR847442A FR847442A FR1320009A FR 1320009 A FR1320009 A FR 1320009A FR 847442 A FR847442 A FR 847442A FR 847442 A FR847442 A FR 847442A FR 1320009 A FR1320009 A FR 1320009A
Authority
FR
France
Prior art keywords
purification
concentration
derived therefrom
live virus
substance derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR847442A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to FR847442A priority Critical patent/FR1320009A/en
Application granted granted Critical
Publication of FR1320009A publication Critical patent/FR1320009A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
FR847442A 1960-12-20 1960-12-20 Process for the purification or concentration of live virus or antigenic substance derived therefrom Expired FR1320009A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR847442A FR1320009A (en) 1960-12-20 1960-12-20 Process for the purification or concentration of live virus or antigenic substance derived therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR847442A FR1320009A (en) 1960-12-20 1960-12-20 Process for the purification or concentration of live virus or antigenic substance derived therefrom

Publications (1)

Publication Number Publication Date
FR1320009A true FR1320009A (en) 1963-03-08

Family

ID=8745119

Family Applications (1)

Application Number Title Priority Date Filing Date
FR847442A Expired FR1320009A (en) 1960-12-20 1960-12-20 Process for the purification or concentration of live virus or antigenic substance derived therefrom

Country Status (1)

Country Link
FR (1) FR1320009A (en)

Similar Documents

Publication Publication Date Title
CH445494A (en) Process for the preparation of benzoxazole derivatives
BE603504A (en) Process for the preparation of gallium-alkyls
FR1266428A (en) Process for the preparation of diamino-pyrimidines
FR1320009A (en) Process for the purification or concentration of live virus or antigenic substance derived therefrom
FR1512307A (en) Process for the preparation of gem-difluorosteroids
CH397663A (en) Process for the preparation of 6a fluorosteroids
BE601233A (en) Animal protein recovery process
BE599589A (en) Process for the preparation of metals-carbonyl
CH388300A (en) Process for the preparation of compounds bearing the B-cyclogeranylidene radical
FR1275570A (en) Process for the purification of 1-dehydro-17alpha-methyl-testosterone
CH450436A (en) Process for the preparation of benzimidazolinones
OA01975A (en) Process for the preparation of araliphatic amines.
FR1288018A (en) Process for the preparation of 16-carboxy-17-alkoxy-18-acyloxy-3-epi-alloyohimbanes
FR1327718A (en) Virus inactivation process
BE610070A (en) Process for the preparation of 2-methyl-4-amino-5-cyano-pyrimidine.
FR1275310A (en) Process for the purification of demethylchlorotetracycline
CH396021A (en) Process for the preparation of derivatives of 2-methylothio-4,6-bis-amino-s-triazine
FR1291963A (en) Process for the preparation of polycarbodiimides
CH412916A (en) Process for the preparation of benzo-1,1-dioxo-1-thia-2,4-diazines
FR1328910A (en) Process for the preparation of 11alpha-hydroxy-a-norprogesterone
FR1260907A (en) Process for the preparation of substituted dihydrobenzothiadiazines
BE599530A (en) Process for the preparation of new benzene-sulfonyl-cyclohexyl-ureas
FR1315730A (en) Process for the preparation of novel substituted diphenylethylamines
FR1261843A (en) Process for the preparation of bis-phosphines
FR1301490A (en) Process for the preparation of 6-demethyltetracyclines